On January 21, 2014, Bayer AG issued three tranches of bonds with a combined nominal volume of €2 billion under the multi-currency European Medium Term Notes program.
On December 19, 2013, Bayer announced its intention to acquire the pharmaceutical company Algeta ASA, Norway. The formal takeover offer at a price of NOK 362 per share in cash was made to Algeta ASA shareholders on January 20, 2014. The offer, which implies an equity value of NOK 17.6 billion (€2.1 billion), is subject to a minimum acceptance level of 90% of the outstanding shares of Algeta ASA by the end of the offer period. The offer period expires at 9:00 a.m. Central European Time on February 24, 2014. If the offer is successful, payment to Algeta shareholders is to be made at the beginning of March 2014.